Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
Clinical trial NCT02065557 · COMPLETED
Trial details
- NCT number
- NCT02065557
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-13
- Primary completion
- 2020-02-07
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.